TCG Crossover Management’s Obsidian Therapeutics OBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.2M Buy
+2,196,138
New +$42.9M 0.85% 31

Other funds holding OBX

TCG Crossover Management's OBX Position: Q3 2026 in Review

TCG Crossover Management opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 2,196,138 shares worth $30.2M. The stake represents 0.85% of the portfolio and ranks #31 among its holdings.

60 funds tracked by Wall St. Rank hold OBX as of Q3 2026.

  • TCG Crossover Management held 2,196,138 shares of Obsidian Therapeutics worth $30.2M as of Q3 2026.
  • Obsidian Therapeutics was a new TCG Crossover Management position in Q3 2026.
  • Obsidian Therapeutics made up 0.85% of TCG Crossover Management's portfolio in Q3 2026, its #31 holding.
  • 60 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.

Based on TCG Crossover Management's 13F filing for Q3 2026, filed 16 Nov 2026.